N@N

Matthew Sykes Maintained (TWST) at Hold with Decreased Target to $43 on, Feb 6th, 2023

Matthew Sykes of Goldman Sachs, Maintained "Twist Bioscience Corporation" (TWST) at Hold with Decreased Target from $50 to $43 on, Feb 6th, 2023.

Matthew has made no other calls on TWST in the last 4 months.

There are 4 other peers that have a rating on TWST. Out of the 4 peers that are also analyzing TWST, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Puneet Souda of "SVB Leerink" Maintained at Hold with Decreased Target to $30 on, Monday, November 21st, 2022

These are the ratings of the 3 analyists that currently disagree with Matthew

---

• Sung Ji Nam of "Scotiabank" Initiated at Buy and Held Target at $33 on, Thursday, January 5th, 2023
• Vijay Kumar of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $36 on, Tuesday, January 3rd, 2023
• Catherine Schulte of "Baird" Maintained at Buy with Decreased Target to $33 on, Monday, November 21st, 2022

Contributing Sources

---